Jurek Kozyra
Founder & Chief Executive Officer Nanovery Ltd.
Seminars
Wednesday 28th January 2026
Nucleic Acid Nanorobotics (NANs): A Novel Platform for Oligonucleotide Therapeutics Bioanalysis
12:00 pm
- Introducing NAN technology and its application for siRNA and ASO quantification
- Highlighting core platform capabilities, including sensitivity and robustness across complex biological matrices
- Exhibiting published evidence demonstrating accuracy, precision, and applicability to live-sample pharmacokinetic bioanalysis
